Jeil Pharmaceutical Co Ltd (271980) — Free Cash Flow Generation Index

Latest as of September 2025: 0.73x

Jeil Pharmaceutical Co Ltd (271980) has a Free Cash Flow Generation Index of 0.73x as of September 2025. Free cash flow of ₩9.68 Billion represents 1% of operating cash flow (₩13.23 Billion). See Jeil Pharmaceutical Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.73x
Free Cash Flow / Operating CF

Free Cash Flow

₩9.68 Billion
KRW

Operating Cash Flow

₩13.23 Billion
KRW

Capital Expenditures

₩3.55 Billion
KRW

Jeil Pharmaceutical Co Ltd Free Cash Flow Generation Index (2018–2024)

Historical FCF Generation Index trend for Jeil Pharmaceutical Co Ltd across 4 annual periods. Explore 271980 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Jeil Pharmaceutical Co Ltd (2018–2024)

Year-by-year Free Cash Flow Generation Index for Jeil Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 271980 company net worth.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2024 -1.06x ₩-3.40 Billion ₩3.21 Billion ₩6.61 Billion ▼ -247.4%
2021 0.72x ₩13.71 Billion ₩19.10 Billion ₩5.34 Billion ▼ -24.6%
2019 0.95x ₩27.56 Billion ₩28.96 Billion ₩1.09 Billion ▲ +82.9%
2018 0.52x ₩11.17 Billion ₩21.45 Billion ₩10.29 Billion
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).